Evidence map›Paper›PMID 37886545›Full record

ArticlebioRxiv : the preprint server for biology2023

A beneficial synonymous substitution in EF-Tu is contingent on genetic background.

Kaitlyn M McGrath, Steven J Russell, Evrim Fer, Eva Garmendia, Ali Hosgel, David A Baltrus, Betül Kaçar

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Kaitlyn M McGrathDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA.
Steven J RussellDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA.
Evrim FerDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA.
Eva GarmendiaDepartment of Medical Biochemistry and Microbiology, Uppsala University, Sweden.
Ali HosgelDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA.
David A BaltrusSchool of Plant Sciences, University of Arizona, Tucson, AZ, USA.
Betül KaçarDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA.
University of Wisconsin–Madison · USUniversity of Arizona · USUppsala University · SE

Funding

Graduate Training in Biochemistry and Molecular BiologyT32GM136536 · NIGMS · UNIVERSITY OF ARIZONA · PI Andrew Paul Capaldi, FRANS E TAX · 2020 to 2026
$2.4M
NIGMS NIH HHS T32 GM136536
6 · The paper itself

Abstract

Synonymous mutations are changes to DNA sequence that occur within translated genes but which do not affect the protein sequence. Although often referred to as silent mutations, evidence suggests that synonymous mutations can affect gene expression, mRNA stability, and even translation efficiency. A collection of both experimental and bioinformatic data has shown that synonymous mutations can impact cell phenotype, yet less is known about the molecular mechanisms and potential of beneficial or adaptive effects of such changes within evolved populations. Here, we report a beneficial synonymous mutation acquired via experimental evolution in an essential gene variant encoding the translation Elongation Factor protein EF-Tu. We demonstrate that this particular synonymous mutation increases EF-Tu mRNA and protein levels, as well as the polysome abundance on global transcripts. Although presence of the synonymous mutation is clearly causative of such changes, we also demonstrate that fitness benefits are highly contingent on other potentiating mutations present within the genetic background in which the mutation arose. Our results underscore the importance of beneficial synonymous mutations, especially those that affect levels of proteins that are key for cellular processes.

Indexed as

elongation factor EF-Tuexperimental evolutionsynonymous mutationTranslation

Identifiers

PMID37886545
PMCPMC10602032
OpenAlexW4386532033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.